The Fund aims to achieve a total return in excess of inflation with a lower risk profile than that of the global equity market.
Name | % Net Assets |
---|---|
NOVARTIS AG | 5.8% |
TELEFONICA SA | 4.7% |
RIO TINTO | 4.4% |
ANHEUSER-BUSCH INBEV SA | 3.7% |
BAYERISCHE MOTOREN WERKE AG | 3.6% |
FRESENIUS MEDICAL CARE AG & CO.KGAA | 3.4% |
BP | 3.4% |
PERNOD-RICARD | 3.2% |
PROSIEBENSAT1 MEDIA AG | 3.1% |
ISHARES MSCI EMERGING MARKETS INDEX | 3.0% |
Key | % Net Assets |
---|---|
NOVARTIS AG | 5.8% |
TELEFONICA SA | 4.7% |
RIO TINTO | 4.4% |
ANHEUSER-BUSCH INBEV SA | 3.7% |
Other | 81.4% |
Date | 21-Nov-2024 |
---|---|
NAV | 289.50p |
Currency | GBP |
Change | -0.50p |
% | -0.17% |
YTD change | 13.90p |
YTD % | 5.04% |
Fund Inception | 22/05/2008 |
---|---|
Fund Manager | Jake Robbins |
TER | 2.05 (31-May-2010) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research